Exhibiting at VIV Asia 2025

Neosci Co., Ltd., headquartered in Bangkok, Thailand, is a leading biotechnology solutions provider specializing in livestock health and nutrition. Established in 2005, the company has steadily grown into one of Southeast Asia’s trusted names in animal biotechnology, offering a wide range of innovative products and services tailored for swine, poultry, and ruminant segments. With a scientific approach to animal health, Neosci merges advanced diagnostics, feed efficiency solutions, and biologically active formulations to improve livestock performance and profitability.

Core Business and Product Portfolio

Neosci provides integrated biotechnology services and products across three main animal sectors:

• Swine Segment:

  • Health monitoring diagnostics
  • Performance-enhancing nutritional additives
  • Gut health modulation technologies

• Poultry Segment:

  • Natural growth promoters
  • Immuno-modulatory agents
  • Probiotic and prebiotic formulations

• Ruminant Segment:

  • Feed efficiency enhancers
  • Herbal formulations for rumen health
  • Trace mineral optimization blends

In addition to these product lines, the company also offers technical consultation services, data-driven livestock analytics, and tailored veterinary solutions to optimize animal health management.

Specialization and Unique Selling Proposition (USP)

Neosci’s specialization lies in its science-backed and diagnostics-led approach to livestock health. Unlike conventional feed or pharma companies, Neosci begins its solution delivery with in-depth farm diagnostics, analyzing key metrics like:

• Pathogen load
• Feed conversion ratios (FCR)
• Immune status of animals

Its unique selling propositions include:

• Integration of biotechnology diagnostics with nutritional interventions
• Use of molecular biology tools to identify and mitigate disease risks
• Customized formulation for farm-specific or region-specific conditions
• Emphasis on antibiotic-free livestock production

Neosci’s model ensures clients not only treat symptoms but also correct the root cause of underperformance, leading to long-term animal welfare and profitability.

Certifications and Quality Compliance

To ensure international-grade reliability and traceability, Neosci adheres to several compliance and certification standards:

• ISO 9001:2015 for Quality Management Systems
• Good Manufacturing Practices (GMP)
• HACCP for feed and feed additive safety
• All products registered with the Department of Livestock Development (DLD), Thailand

The company operates under a fully traceable supply chain, with raw materials and final outputs subject to multi-point quality inspections and validated via third-party laboratories.

Export and Shipment Records

While Thailand remains its primary market, Neosci has actively expanded its footprint across Southeast Asia and beyond. Based on trade and partner reports:

• Active clients in Vietnam, Philippines, Myanmar, and Indonesia
• Over 150 international B2B shipments since 2018
• Increasing traction for biotech-based poultry and swine solutions in antibiotic-reduction programs
• Estimated export revenue between USD 3–5 million over the past five years

Neosci collaborates with regional distributors and veterinary service providers to penetrate emerging livestock markets where biosecurity and performance are top concerns.

Financial and Operational Capabilities

As a privately held Thai company, Neosci demonstrates strong internal capabilities in both research and operations:

• Modern manufacturing plant located near Bangkok with high-volume production lines for liquid, powder, and encapsulated forms
• In-house R&D division staffed with microbiologists, veterinarians, and nutritionists
• Partnerships with local universities and biotechnology research centers
• Ability to conduct on-farm trials and validations, strengthening product credibility

Estimated annual revenue is in the range of THB 150–200 million (approx. USD 4.5–6 million), based on industry benchmarks and market size.

Target Market and Industry Positioning

Neosci primarily targets:

• Medium to large-scale commercial farms
• Livestock integrators
• Veterinary professionals and consultants
• Distributors of animal health products

With increasing global pressure on reducing antibiotic usage in animal farming, Neosci is positioned as a next-generation biotechnology partner, helping farms transition to safer, residue-free, and sustainable models of production.

Recognitions and Industry Engagement

Neosci actively engages with the livestock and agri-biotech communities through:

• Participation in VIV Asia, ILDEX, and AgriLivestock Expo Thailand
• Collaborations with Chulalongkorn University and other academic bodies for joint research
• Involvement in national policy forums for promoting responsible antibiotic usage in animal production

The company has also been featured in several Thai agribusiness media outlets for its innovative role in reshaping livestock health protocols using scientific diagnostics and biotech-based interventions.

Neosci Co., Ltd. continues to pioneer the convergence of animal biotechnology and nutrition, offering sustainable, effective, and data-driven solutions to improve animal welfare and productivity across Asia’s livestock sector.